1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for ORGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2018. Start Trial.
Date Value
September 11, 2026 -70.44%
September 10, 2026 -68.52%
September 09, 2026 -67.89%
September 08, 2026 -66.46%
September 04, 2026 -66.00%
September 03, 2026 -66.94%
September 02, 2026 -65.92%
September 01, 2026 -68.35%
August 31, 2026 -66.60%
August 28, 2026 -66.02%
August 27, 2026 -64.05%
August 26, 2026 -63.69%
August 25, 2026 -62.74%
August 24, 2026 -65.85%
August 21, 2026 -59.73%
August 20, 2026 -59.83%
August 19, 2026 -57.37%
August 18, 2026 -60.92%
August 17, 2026 -63.64%
August 14, 2026 -61.91%
August 13, 2026 -64.15%
August 12, 2026 -62.99%
August 11, 2026 -59.05%
August 10, 2026 -59.17%
August 07, 2026 -58.85%
Date Value
August 06, 2026 -46.44%
August 05, 2026 -47.68%
August 04, 2026 -48.48%
August 03, 2026 -48.12%
July 31, 2026 -48.70%
July 30, 2026 -47.42%
July 29, 2026 -47.17%
July 28, 2026 -49.60%
July 27, 2026 -49.30%
July 24, 2026 -49.68%
July 23, 2026 -51.20%
July 22, 2026 -48.76%
July 21, 2026 -41.23%
July 20, 2026 -39.82%
July 17, 2026 -39.91%
July 16, 2026 -40.20%
July 15, 2026 -38.21%
July 14, 2026 -47.88%
July 13, 2026 -47.21%
July 10, 2026 -45.45%
July 09, 2026 -44.84%
July 08, 2026 -46.65%
July 07, 2026 -41.18%
July 06, 2026 -41.65%
July 02, 2026 -41.73%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
cbdMD, Inc. -31.02%
Guardian Pharmacy Services, Inc. 44.03%
ACADIA Pharmaceuticals, Inc. 15.00%
Agenus, Inc. 46.41%
Alnylam Pharmaceuticals, Inc. -46.93%